Announcements Trials
Browse Landscape

Phase

Phase NA 85Phase 2 75Phase 1 52Phase 3 39Phase 1/2 14Phase EARLY_PHASE1 6Phase 2/3 5Phase 4 3

Status

Unknown 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 376Other hematologic neoplasm 145Thoracic 144Breast 139Genitourinary 133Lymphoid 115Head & Neck 80Gynecologic 76CNS 48Myeloid 40Plasma cell 36Dermatologic 34Tumor-Agnostic 32Sarcoma 30Endocrine 22Other solid neoplasm 13Other 13Classical hematology 12NET 9Other neoplasm 5

Conditions

TP53 1Primary Malignant Neoplasm of Ovary 1Precancerous Conditions 1Older Patients 1Keratosis, Actinic 1Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Decitabine 4Busulfan 3Cyclophosphamide 2venetoclax 1fludarabine 1Paclitaxel 1Influenza Vaccines 1Celecoxib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Other neoplasm × Clear all
NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting
160 enrolled
Other neoplasm

Older Patients

NCT04123392 2019-10-10

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

TP53

NCT04098653 2019-09-23

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

Allogeneic Hematopoietic Stem Cell Transplantation

NCT02159820 2014-06-10

DAC and CT

Chinese PLA General Hospital

Phase 2/3 Unknown
500 enrolled
Other neoplasm

Primary Malignant Neoplasm of Ovary

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

University of Alabama at Birmingham

Phase 2/3 Withdrawn
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡